Sanofi builds sales and distribution platform to surf China’s market growth
This article was originally published in Scrip
Executive Summary
Sanofi is planning to accelerate its expansion into both the prescription and general healthcare sectors in China, as part of which it is aiming for revenues of about €100 million ($141 million) from its consumer healthcare business in the country.